US Patent Issued to Helsinn Healthcare on Jan. 28 for "Physiologically balanced injectable formulations of fosnetupitant" (Italian Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,109, issued on Jan. 28, was assigned to Helsinn Healthcare SA (Pazzallo, Switzerland).

"Physiologically balanced injectable formulations of fosnetupitant" was invented by Alessio Venturini (Varese, Italy) and Roberta Cannella (Varese, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "Injectable dosages and formulations of fosnetupitant and pharmaceutically acceptable salts thereof are provided that are efficacious, chemically stable and physiologically balanced for safety and efficacy."

The patent was filed on Nov. 15, 2022, under Application No. 17/986,934.

*For further information, including images, charts and tables, please visit: http://pat...